Six forces will shape professional beauty in 2027, and every one of them will still be pressing on the industry in 2030

A trend happens to you and then stops happening, whereas a force applies pressure in the same direction for years, and the only decision a business gets to make about a force is whether it pulls it or is pulled by it. The 2027 Professional Beauty & Aesthetic Industry Trend Report is built on six of them, and they are the levers I would be watching hardest if I were setting a brand or clinic budget for next year. The backdrop matters here. Australian hairdressing and beauty services revenue sits at around A$12.5 billion and went backwards by just under one per cent last financial year, while the number of businesses competing for it kept climbing. The money is still in the industry and is being redistributed toward wellness, longevity, product, membership and experience, and toward the operators who learned to talk fluently about a changed client, and these six forces explain where it is going.

The first is regeneration, now four years out. The 2026 edition called the move from peeling the skin back to building it up, and it has held. Galderma's injectable aesthetics business grew 13.2 per cent across the first nine months of 2026, with Sculptra in double-digit growth in every geography, and in Australia searches for PDRN rose 490 per cent and for exosomes 183 per cent in the year to July 2026. Two things have changed since last year. Fillers and biostimulators slowed sharply at Galderma in the third quarter, to 4.8 per cent against 24.1 per cent for neuromodulators, which reads as the biostimulator boom settling into a category with ordinary growth rates rather than accelerating as a fashion, and every by-2030 projection we made last year now has twelve months less runway. By 2030 I expect "regenerative" to stop being an adjective and become a menu category, with aesthetics and dermal science structured around a client's skin over years rather than a treatment on a Tuesday, and with regulators treating exosomes and polynucleotides as the biologicals they are.

The second is correction giving way to enhancement. The language people use about their own appearance in peer communities is moving, measurably, from fixing toward making the most of. Reddit's People's Beauty Index (August 2026) found posts using "embrace", "highlight", "enhance" and "emphasise" up 220 per cent year on year, while posts using "fix", "hide", "cover", "correct" and "conceal" fell 32 per cent. People have kept having treatment, so what has changed is the sales frame underneath it. Allergan Aesthetics' own global research (vendor-commissioned, more than 12,000 consumers in nine countries) found 74 per cent of people prefer results that are hard to notice and 71 per cent worry about looking overdone, and RealSelf's first-quarter 2026 data showed Botox interest down 12 per cent while Sculptra rose 25 per cent. By 2030 the consultation script built on "concerns" and "problem areas" will read as dated to clients and the before-and-after grid will have given way to the progress-over-time record. The clinics that moved their language first will find that Ahpra's advertising rules and their clients' instincts were pushing them the same way all along.

The third force carries more weight than the other five, because the GLP-1 client is now the default client. More than a million Australians were dispensed a GLP-1 weight-loss medicine in the year to May 2026, roughly five per cent of all adults, almost all of it paid for privately at between $260 and $700 a month, and three in four of the people on the two leading brands are women (IQVIA, June 2026). That maps almost exactly onto the professional beauty client base. Medicare-funded bariatric surgery more than halved over the same four years, so weight loss has moved from the operating theatre to the fridge door, and clinics now see the result without the surgical aftercare pathway that used to come with it. The client on or coming off a GLP-1 is a standing feature of practice in the same way the client on the pill or on Roaccutane is, and the face, skin, scalp and body arriving for treatment have been shaped by a medication the therapist did not prescribe and cannot advertise. The mistake is to read this as a treatment opportunity, and the handful of clinics running an "Ozempic face" package are almost certainly breaching the TGA's prohibition on advertising prescription-only medicines by name. The better reading is that the baseline client has changed and the consultation has to change with it, starting with a neutral question about weight-loss medication on every consultation form, a team that can recognise what rapid metabolic weight loss does to skin and hair, language about firmness and density that treats the change as the next chapter of a result the client is proud of, and a referral relationship with the GPs and telehealth prescribers your clients already use. GLP-1 shows up in eight of the report's nine trends, which is why it is the only force with a full chapter of its own.

The fourth is AI moving from the scanner to the operating system. In the 2026 edition AI lived in the consultation room, analysing pores and pigment, and this year it moved to the front desk and the inbox, with Fresha launching an AI Concierge to its 140,000 businesses in May 2026 and Phorest following with Front Desk AI in June. On the client's side, three in four American beauty shoppers have used a large language model to research beauty and wellness and a quarter now call AI their primary research source (BCG and WWD, 2026). The counterweight is trust, because 78 per cent of consumers prefer advertising made by people (Canva, May 2026) and visible AI in marketing is four times more likely to cost a brand trust than to build it (Klaviyo, 2026), with both samples including Australia. By 2030 the machine takes the booking, the reminder, the follow-up and the first draft, and the client arrives having asked an agent which clinic to choose. The businesses that win are the ones that automated everything on a screen and kept everything with a human in it unmistakably human.

The fifth is compliance as positioning, because three regulators are moving in the same direction at the same time, which almost never happens. Ahpra's cosmetic procedure guidelines have applied across every registered profession since 2 September 2025, requiring a real-time consultation for every injectable prescription and banning influencer testimonials. The TGA has named therapeutic goods used in cosmetic procedures one of its compliance priorities for 2026 and 2027, and in the second half of 2025 alone it requested the removal of more than a thousand advertisements and profiles and issued more than five thousand warning letters across all categories. In New South Wales, the Medicines, Poisons and Therapeutic Goods Act commences on 5 November 2026, requiring every substance used in cosmetic procedures to be ARTG-listed and every prescriber to personally review the patient. Every one of these changes pushes the industry away from promotional, advertised treatment selling and toward ongoing consultative programs, which is where the money was heading anyway, and by 2030 the clinics that got there first will have found that compliance became a positioning advantage rather than a cost.

The sixth is the return of the room. When everything becomes machine-mediated, the things that cannot be faked go up in value, and the market is already repricing them. Global experiential marketing spend grew 10.5 per cent and has passed its pre-pandemic level (PQ Media), and 84 per cent of consumer marketers are increasing event spend in 2026 (EventTrack). The 2026 Edelman Trust Barometer found people globally now trust their neighbours more than their national government, 64 per cent against 53. Authority used to flow from credentials and stages, and it now flows from proximity and peers, which for a salon or clinic means the four-to-six-weekly appointment and the person who remembers what a client said last time are the most defensible assets the business owns. By 2030 the salon and clinic will be understood as the highest-frequency touchpoint in a client's entire health ecosystem, and the room of twelve clients and one good question will have replaced the launch night and the demo evening.

None of these forces started inside professional beauty, and that is exactly why they are worth planning around, because they will keep applying pressure whatever any single brand or clinic decides to do. The full report traces each force through to the trends it feeds and carries every projection to 2030, and it is free to download at insideindustry.co/reports.

If you are building your 2027 plan now and want to work out which of these levers to pull first for your own business, a Strategic Session is where we do exactly that, with the data sitting underneath every recommendation.